ABMIUM target intelligence
basal cell adhesion molecule (Lutheran blood group)
BCAM (basal cell adhesion molecule; Lutheran blood group glycoprotein; CD239) is an immunoglobulin-superfamily cell-surface protein and laminin receptor involved in cell-matrix adhesion. This catalogue-backed target record connects verified human BCAM identity with Abmium research reagents.
Read full target overviewABMIUM research catalogue
Loading products for BCAM…
Research context & evidence
Target information is kept separate from product-level validation so you can review the biology and the reagent evidence independently.
BCAM encodes the Lutheran blood group glycoprotein, a transmembrane immunoglobulin-superfamily receptor that binds laminin and participates in cell-matrix adhesion. Its extracellular immunoglobulin-like domains support recognition of laminin, while BCAM polymorphisms also define antigens in the Lutheran and Auberger blood group systems.
BCAM/CD239 is studied in laminin-receptor biology, epithelial and endothelial cell adhesion, cell-matrix interactions and Lutheran blood group antigen research. Researchers use BCAM measurements and perturbations to investigate how laminin-dependent adhesion and surface-antigen variation affect cellular behaviour. Confirm species, assay format, application and product-level validation for each Abmium reagent.
Names used across publications, databases and supplier catalogues.
